ICUI ICU Medical (ICUI) Q2 FY26 earnings call
ICU Medical delivered a strong second quarter, driven by robust organic growth in its core Consumables and IV Systems businesses, leading to raised full-year adjusted EBITDA and EPS guidance. The company made significant progress on debt reduction, nearing its leverage target, and continues to advance its strategic vision for a comprehensive infusion therapy portfolio, despite ongoing macroeconomic headwinds from currency and tariffs. Innovation in new product cycles and operational efficiencies are expected to drive future margin expansion and predictable revenue growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
ICUI operating KPIs by quarter
| KPI | Mar 2026 Q1 FY26 | This call Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Capital expenditures General maintenance and capacity expansion at our facilities as well as placement of revenue-generating infusion pumps with customers outside the US | $11MDuring the quarter, we invested $9 million of cash spend for quality system and product-related remediation activities, $17 million on restructuring and integration and $11 million on CapEx for general maintenance and capacity expansion at our facilities as well as placement of revenue-generating infusion pumps with customers outside the USSource: earnings call transcript | $19MDuring the quarter, we invested $11 million of cash spend for quality system and product-related remediation activities, $11 million on restructuring and integration and $19 million on CapEx for general maintenance and capacity expansion at our facilities as well as placement of revenue-generating infusion pumps with customers outside the USSource: earnings call transcript | +72.7% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.